Germany has depended on imports of medical cannabis, mainly from Canada and the Netherlands FRANKFURT — Germany has awarded contracts to supply domestically grown... Germany to launch home-grown cannabis farming as Aurora, Aphria subsidiaries win contracts

Germany has depended on imports of medical cannabis, mainly from Canada and the Netherlands

FRANKFURT — Germany has awarded contracts to supply domestically grown cannabis to two Canadian companies, as it seeks to develop its own medicinal marijuana industry and reduce reliance on imports.

Drugs regulator BfArM said on Wednesday it would purchase 4,000 kg and 3,200 kg of cannabis over four years from German production subsidiaries of Canada’s Aurora Cannabis and Aphria, respectively.

Another tender over a four-year harvest of 3200 kg has been delayed because an unidentified bidder who lost out is challenging the procedure with a regulator.

The first home-grown harvest is slated for late 2020, the German drugs watchdog said in its statement, describing the tender as an “important step for the supply of medical-grade cannabis grown in Germany to critically ill patients.”

Aurora shares rose on April 5, when the company announced it was one of the winners in the German production tender, citing preliminary results. [Read More @ Financial Post]

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )